Read The Latest Posts From Our Newsletter.
Our newsletter tracks recent developments in the biotech industry. We explore genetic medicine, AI in biotech and the examine the breakthrough science that is driving our new, advanced medicines.
Kevin Curran, the Bridgepoint Bio founder, is the author of our newsletter. Visit this link to sign up for Kevin’s substack newsletter.
2102, 2024
How much does it cost to develop a new drug?
...and how can we lower that number?
802, 2024
If you could develop a drug against any disease…
What are the considerations when deciding which disease to pursue?
201, 2024
How to discover a new drug
Step 1: Find a novel target
1204, 2023
Recorded lecture on AAV gene therapy now available
Hello friends,We are currently seeing the first wave of gene [...]